microdose vs regular dose glp-1 Microdosing 2026: 0.1mg Chart + Tolerance Schedule Guide Microdose GLP-1: Dosing, Biomarkers &

Pricing They offer a monthly subscription starting at $249 per month

January 25, 2023

Retatrutide is in Phase 3 trials and is not FDA-approved as of June 2026

Zepbound) to be covered if the preferred option is not clinically inappropriate

While tirzepatide and retatrutide share the common goal of weight loss and improving metabolic health, the unique triple-hormone receptor agonism of retatrutide sets it apart, offering the potential for more significant weight loss and sustained weight reduction

Prior Authorization and CPB 1014 Aetna's GLP-1 prior authorization requirements are governed by Clinical Policy Bulletin (CPB) 1014 and administered through CVS Caremark's PA portal